Quick Answer
CYTOKINETICS INC reported Revenue (ASC 606) of $88.04 million for fiscal year 2025.
CYTOKINETICS INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $88.04M | +376.6% |
| 2024 | $18.47M | +145.3% |
| 2023 | $7.53M | -92.0% |
| 2022 | $94.59M | +34.3% |
| 2021 | $70.43M | +26.2% |
| 2020 | $55.83M | +107.8% |
| 2019 | $26.87M | -14.7% |
| 2018 | $31.50M | +135.6% |
| 2017 | $13.37M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.94M | +318.1% | -97.1% |
| June 30, 2025 | $66.77M | +26714.9% | +4128.6% |
| March 31, 2025 | $1.58M | +89.1% | +241.0% |
| September 30, 2024 | $463.0K | +22.5% | +85.9% |
| June 30, 2024 | $249.0K | -71.3% | -70.2% |
| March 31, 2024 | $835.0K | -81.9% | +120.9% |
| September 30, 2023 | $378.0K | -85.0% | -56.4% |
| June 30, 2023 | $867.0K | -99.0% | -81.2% |
- CYTOKINETICS INC showed an increase of +376.6% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2017–2025 period, CYTOKINETICS INC’s revenue (asc 606) has grown by 558.6% (from $13.37 million to $88.04 million).
- The most recent figure is from CYTOKINETICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: